期刊文献+

小剂量奥氮平防治化疗后恶心呕吐的临床观察 被引量:11

The clinical observation of small dose of olanzapine to prevent and control nausea and vomiting after chemotherapy
下载PDF
导出
摘要 目的:评估小剂量奥氮平防治化疗所致恶心呕吐(CINV)的疗效。方法:80例需化疗患者随机分为两组,研究组(40例)和对照组(40例)。两组在化疗前给予静脉注射托烷司琼5mg,地塞米松5mg,研究组于化疗当天开始给予口服奥氮平5mg/d,观察两组化疗后恶心呕吐情况。结果:研究组和对照组急性呕吐发生率分别为22.5%(9/40)和47.5%(19/40),差异具有统计学意义(P<0.05),迟发型恶心呕吐的发生率分别为17.5%(7/40)和37.5(15/40),差异具有统计学意义(P<0.05)。结论:小剂量奥氮平(5mg/d)对防治化疗后恶心呕吐疗效明显。 Objective:To evaluate the curative effect of low -dose olanzapine in prevention and treatment of chemotherapy induced nausea and vomiting.Methods:80 cases of chemotherapy patients were randomly divided into two groups,the test group (40 cases),control group (40 cases).Before chemotherapy the test group and the control group given intravenously navoban tropisetron 5 mg and dexamethasone 5 mg,the test group were given olanzapine 5 mg daily started on the day of chemotherapy.Then two groups of nausea and vomiting after chemotherapy were ob-served.Results:The test group and the control group acute vomiting incidence was 22.5%(9 /40)and 47.5%(19 /40),with statistical significance (P 〈0.05),late onset incidence of nausea and vomiting were 17.5%(7 /40)and 37.5(15 /40),with statistical significance (P 〈0.05).Conclusion:Small dose of olanzapine (5mg/d)for preven-tion of nausea and vomiting after chemotherapy curative effect is obvious.
出处 《现代肿瘤医学》 CAS 2015年第18期2673-2675,共3页 Journal of Modern Oncology
关键词 奥氮平 化疗 恶心呕吐 olanzapine chemotherapy nausea and vomiting
  • 相关文献

参考文献10

  • 1Wiser W, Berger A. Practical management of chemotherapy - in- duced nansea and vomiting[ J]. Oncollogy( Williston Park) ,2005, 19:637 - 645.
  • 2邢金云,李学.含顺铂方案化疗的肿瘤患者40例血钠分析[J].中华临床医师杂志(电子版),2011,5(6):1779-1780. 被引量:4
  • 3Navari RM, Gray SE, Kerr AC. Olanzapine versus aprepitant for the prevention of chemotherapy - induced nausea and vomiting : A ran- domized phase Ⅲ triM[ J]. J Support Oncol,2011,9 :188 -195.
  • 4Passik SD,Kirsh KL,Theobald DE, et al. A retrospective chart re-view of the use of olanzapine for the prevention of delayed emesisin cancer patients[ J]. J Pain Symptom Manage,2003,25:485 -488.
  • 5马剑,韩正祥.化疗引起的恶心呕吐机制研究进展及其对策[J].徐州医学院学报,2010,30(9):627-630. 被引量:53
  • 6Elizabeth GR, Ettinger DS. 5 - H33 receptor antagonists for the prevention of chemotherapy - induced nausea and vomiting. A com- parison of their pharmacology and clinical efficacy [ J ]. Drugs, 1998,55 : 173 - 189.
  • 7Lindley C, Goodin S, McCune J, et al. Ondansetron, prochlorpera- zine, and dexamethasone have similar effects on prevention of de-layed chemotherapy - induced nausea and vomiting [ J ]. Cancer Treatment Reviews,2006,32:50 - 54.
  • 8Bymaster F, Perry KW, Nelson DL, et al. Olanzapine.. Abasic sci- ence update [ J ]. Br J Psychiatry Suppl, 1999,37:36 - 40.
  • 9He H, Richardson JS. A pharmacological, pharmacokinetic and clin- ical overview of risperidone, a new antipsycbotic that blocks seroto- nin 5 - HT2 and dopamine D2 receptors [ J ]. Int Clin Psychophar- macol, 1995,10 : 19 - 30.
  • 10Schotte A, Janssen PF, Gommeren W, et al. Risperidone compared with new and reference antipsychotic drugs: In vitro and in vivo re- ceptor binding[ J]. Psychopharmacology, 1996:57 - 73.

二级参考文献40

  • 1李明焕,孔莉,张品良.化疗诱发低钠血症2例[J].临床肿瘤学杂志,2006,11(3):240-240. 被引量:5
  • 2李柱,陈晓秋,申东兰.肺癌化疗并发严重低钠血症1例[J].广东医学,2006,27(7):1112-1112. 被引量:2
  • 3陈文彬.诊断学[M].7版.北京:人民卫生出版社,2008:35-37.
  • 4Jordan K,Kasper C,Schmoll HJ.Chemotherapy-induced nausea and vomiting:current and new standards in the antiemetic prophylaxis and treatment[J].Eur J Cancer,2005,41(2):199-205.
  • 5Morrow GR,Roscoe JA,Kirshner JJ,et al.Anticipatory nausea and vomiting in the era of 5-HT3 antiemetics[J].Support Care Cancer,1998,6(3):244-247.
  • 6Abrahamsson H,Thorén P.Vomiting and reflex vagal relaxation of the stomach elicited from heart receptors in the cat[J].Acta Physiol Scand,1973,88(4):433-439.
  • 7Fukui H,Yamamoto M,Sato S.Vagal afferent fibers and peripheral 5-HT3 receptors mediate cisplatin-induced emesis in dogs[J].Jpn J Pharmacol,1992,59(2):221-226.
  • 8Racké K,Reimann A,Schwrer H,et al.Regulation of 5-HT release from enterochromaffin cells[J].Behav Brain Res,1996,73(1-2):83-87.
  • 9Higgins GA,Kilpatrick GJ,Bunce KT,et al.5-HT3 receptor antagonists injected into the area postrema inhibit cisplatin-induced emesis in the ferret[J].Br J Pharmacol,1989,97(1):247-255.
  • 10Carpenter DO,Briggs DB,Strominger N.Peptide-induced emesis in dogs[J].Behav Brain Res,1984,11(3):277-281.

共引文献54

同被引文献91

引证文献11

二级引证文献30

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部